This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

September 21-24, 2020
Proudly part of BioPharm AmericaDelivered Digitally | US Eastern Daylight Time

Yihong Qiu, Ph.D.
Senior Research Fellow, Formulation Sciences at Abbvie


Yihong Qiu is currently Senior Research Fellow, Formulation Sciences, R&D, AbbVie. His in-depth knowledge and extensive experience encompass various stages of product lifecycle, including preformulation, drug delivery technology, product/process design, biopharmaceutics & pharmacokinetics, formulation & process development, scale-up, technology transfer, manufacturing trouble-shooting, IP and regulatory registration for NCE’s and line-extension products. During his nearly 28-year tenure with Abbott/AbbVie, his work has resulted in marketed IR and MR products, patented drug delivery technologies, IVIVC’s and biowaivers approved by global regulatory agencies. He also plays a key role in the product LCM, IP strategy, scientific and regulatory assessment of product opportunities. His research interests include modified-release delivery, enhancing dissolution and oral bioavailability, IVIVC, drug delivery technology and science-based regulations. Dr. Qiu is an elected fellow of the American Association of Pharmaceutical Scientists (AAPS) and a member of USP Expert Committee (2010-15). He has more than 60 publications in journals and books, over 35 patents granted or pending, and numerous invited presentations at conferences, universities and regulatory agencies.

Agenda Sessions

  • Regulatory and Scientific Justifications for CMC Changes - Case Studies of Modified Release Products